Analysis of efficacy of contrast-enhanced ultrasonography with Sonazoid on treatment evaluation after local therapy for hepatocellular carcinoma (Comparison with transvenous contrast-enhanced computed tomography)

Analysis of efficacy of contrast-enhanced ultrasonography with Sonazoid on treatment evaluation after local therapy for hepatocellular carcinoma (Comparison with transvenous contrast-enhanced computed tomography) - Efficacy of contrast-enhanced ultrasonography on treatment evaluation after local therapy for hepatocellular carcinoma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015392

Enrollment

100

Registered

2014-10-10

Start date

2008-08-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Microbubble contrast agents

Sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1. Egg allergy 2. Severe lung disease 3. Severe heart disease 4. Allergic to iodine 5. Difficult to follow up in our hospital 6. Determined to be ineligible by the physician in charge for any other reason

Design outcomes

Primary

Measure	Time frame
To evaluate the treatment evaluation for hepatocelluar carcinoma after local therapy using contrast-enhanced ultrasonography compared with contrast-enhanced computed tomography in six months after the treatment	—

Countries

Japan

Contacts

Public ContactHitoshi Maruyama

Chiba University Graduate School of Medicine Department of Gastroenterology and Nephrology

maru-cib@umin.ac.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026